滝山由美

タキヤマユミ | Takiyama Yumi

所属機関・部署：
職名：准教授

研究分野 (1件)：代謝、内分泌学

研究キーワード (1件)：糖尿病腎症

競争的資金等の研究課題 (3件)：

論文 (29件)：

Suratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu, Mayumi Nagashimada, Naoto Nagata, Yumi Takiyama. A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation. Diabetology International. 2023
Takao Takiyama, Toshihiro Sera, Masanori Nakamura, Masato Hoshino, Kentaro Uesugi, Shin-Ichi Horike, Makiko Meguro-Horike, Ryoichi Bessho, Yuri Takiyama, Hiroya Kitsunai, et al. A maternal high-fat diet induces fetal origins of NASH-HCC in mice. Scientific reports. 2022. 12. 1. 13136-13136
別所瞭一, 滝山貴央, Promsuwan Suratsawadee, 宿田夕季, 橘内博哉, 澤本一樹, 竹田安孝, 坂上英充, 滝山由美. Nrf2活性化剤によるTFAM活性化とSTING抑制作用. 糖尿病. 2021. 64. Suppl.1. I-3
Ryoichi Bessho, Yumi Takiyama, Takao Takiyama, Hiroya Kitsunai, Yasutaka Takeda, Hidemitsu Sakagami, Tsuguhito Ota. Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy. Scientific reports. 2019. 9. 1. 14754-14754
Tomoe Abe, Yasutaka Takeda, Ryoichi Bessho, Kentaro Sakai, Tomonobu Nakamura, Tsuyoshi Yanagimachi, Hidemitsu Sakagami, Yukihiro Fujita, Atsuko Abiko, Yumi Takiyama, et al. Two sibling cases of mitochondrial diabetes mellitus presented with different clinical courses and related complications. Journal of the Japan Diabetes Society. 2019. 62. 3. 162-169

MISC (12件)：

Takao Takiyama, Ryoichi Bessho, Kazuki Sawamoto, Yumi Takiyama. Maternal Overnutrition Causes DNA Alkylation in Fetal Liver, Suppresses FasL, and Upregulates HIF-1 Signaling Pathway in Neonatal Liver in Nonalcoholic Steatohepatitis (NASH)-Based Hepatocellular Carcinoma in Offspring. DIABETES. 2020. 69
Ryoichi Bessho, Yumi Takiyama, Manami Maeda, Kuralay K. Atageldiyeva, Yukihiro Fujita, Masakazu Haneda. Zinc; HIF-1 Mimetic in Human Renal Proximal Tubular Cells. DIABETES. 2016. 65. A137-A137
Yumi Takiyama, Manami Maeda, Kuralay K. Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Atsuko Abiko, Masakazu Haneda. A New Player in Diabetic Nephropathy: Metallothionein 3 Is a Target for Hypoxia Inducible Factor-1. DIABETES. 2015. 64. A142-A142
Y. Takiyama, M. Maeda, K. K. Atageldiyeva, T. Yanagimachi, J. Honjo, Y. Fujita, Y. Makino, M. Haneda. Zinc exerts anti-fibrotic action by inhibiting TGF-beta1-induced type I collagen and fibronectin in human renal proximal tubular cells. DIABETOLOGIA. 2014. 57. S480-S480
Yumi Takiyama, Ryoichi Bessho, Manami Maeda, Kuralay K. Atageldiyeva, Tsuyoshi Yanagimachi, Jun Honjo, Yukihiro Fujita, Yuichi Makino, Masakazu Haneda. SGLT2 Inhibitor Luseogliflozin (TS-071) Protects from Diabetic Nephropathy in an Animal Model of Type 2 Diabetes. DIABETES. 2014. 63. A136-A136

学位 (1件)：

所属学会 (9件)：

米国甲状腺学会 , 米国内分泌学会 , 米国腎臓学会 , 米国糖尿病学会 , 日本甲状腺学会 , 日本糖尿病合併症学会 , 日本内分泌学会 , 日本糖尿病学会 , 日本内科学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

滝山 由美